Have you ever had one of those days where you wake up and you just feel like your internal battery is stuck at five percent? No matter how much coffee you drink or how much you try to power through, the charger just is not working. For most of us, that is a bad Tuesday. But for millions of people, that is every single day of their lives, and it often comes with a side helping of medical professionals telling them it is all in their head. Today's prompt from Daniel is about myalgic encephalomyelitis, or chronic fatigue syndrome, along with fibromyalgia. He wants us to look into why these conditions have been so poorly understood for so long and what the science is finally telling us here in early twenty twenty-six. We are talking about an invisible epidemic that affects between seventeen and twenty-four million people worldwide. For decades, these patients were told their symptoms were psychosomatic, but the narrative shifted dramatically in late twenty twenty-five. We have moved from the era of no biomarkers to a breakthrough with nanoneedle technology and the massive BioQuest study.
It is a massive topic, Corn, and honestly, one of the most significant shifts in medical history is happening right under our noses. I am Herman Poppleberry, and I have been diving deep into the research coming out of the last few months because we are truly at a turning point. For decades, these patients were the ghosts of the medical system. They had profound, life-altering symptoms, but because standard blood work like a complete blood count or a basic metabolic panel came back normal, they were often dismissed. Doctors would suggest exercise or therapy, which we now know can actually be incredibly dangerous for this specific population. The lack of a biomarker was used as a weapon against them, as if the failure of our current tests to find the problem was proof that the problem did not exist.
It feels like a massive failure of the scientific method, honestly. If a patient says they are suffering and your test says they are fine, the logical conclusion should be that your test is not looking for the right thing, not that the patient is making it up. But it seems like the tide has finally turned, especially with the research that has come out in the last year or so. Before we get into the heavy science, let's establish the definitions, because people often lump these together. We are talking about myalgic encephalomyelitis, which people often call chronic fatigue syndrome or M E C F S, and then there is fibromyalgia. They overlap quite a bit, but they are distinct, right?
They are distinct, though they often travel together. M E C F S is defined primarily by something called post-exertional malaise, or P E M. This is the absolute hallmark of the disease. It is not just being tired after a walk. It is a systemic crash where your symptoms get significantly worse twelve to forty-eight hours after physical, cognitive, or even emotional exertion. Your body's energy production system basically breaks down. Fibromyalgia, on the other hand, is characterized more by widespread musculoskeletal pain, sleep disturbances, and memory issues, often called fibro fog. While many people have both, the core of M E C F S is that energy failure and the crash, while the core of fibro is that systemic pain and sensory processing issue. And we have to talk about the long covid bridge here. The N I H R E C O V E R study from twenty twenty-five found a seven point five times increased risk of developing M E C F S after a covid nineteen infection. When you have millions of people suddenly developing post-viral syndromes that look almost identical to M E C F S, the global medical bodies could no longer look the other way.
That scale is what changed everything. It is hard to tell ten million new patients they are all having the same psychological delusion at the same time. Why has it taken so long for the medical establishment to catch up? Is it just the lack of a blood test, or is there something deeper in how we train doctors?
It is an epistemological failure. Medicine is taught in silos. If you have a heart problem, you see a cardiologist. If you have a lung problem, you see a pulmonologist. But M E C F S and fibromyalgia are multi-systemic. They affect the immune system, the nervous system, the gut, and the mitochondria in every single cell. If the problem is everywhere, it can look like it is nowhere to a specialist who is only looking at one organ. Plus, there is a historical gender bias. These conditions affect women at a ratio of about three to one. Historically, when women presented with complex, multi-system pain and fatigue, it was labeled as hysteria or anxiety. We are still untangling that mess in twenty twenty-six.
Let's get into the hard science of why we are finally seeing the light. You mentioned a breakthrough in December twenty twenty-five that people are calling the something in the blood paper. That sounds like a sci-fi horror movie title, but what does it actually mean for the pathology?
It is one of the most elegant and terrifying studies I have seen. Researchers took serum, which is the liquid part of the blood, from M E C F S and long covid patients and applied it to healthy muscle cells in a lab. Those healthy cells, which had no previous issues, suddenly started showing the same energy defects as the patient cells. Their ability to process oxygen dropped, and they could not generate A T P, which is the fuel our cells use. This suggests there is a circulating factor in the blood—something that is actively poisoning the mitochondria or interfering with the metabolic pathway. It is not that the cells are broken; it is that the environment they are swimming in is toxic.
When you say circulating factor, what are we talking about? Is it a rogue protein, or is it related to the viral persistence theory?
It is likely a combination. We are seeing strong evidence of autoantibodies. In fibromyalgia, there was a landmark study where researchers took I g G antibodies from patients and injected them into mice. The mice then developed the same pain hypersensitivity as the humans. That is a smoking gun for an autoimmune mechanism. On the M E C F S side, the viral persistence angle is gaining a lot of ground. In early twenty twenty-five, the R E C O V E R study confirmed that some people have reservoirs of the virus hiding in their tissues—like the gut or the brain—long after the initial infection is gone. This keeps the immune system in a state of constant, low-level war, which eventually leads to this systemic exhaustion. The body is trying to fight a ghost that it can never quite kill.
And the lack of biomarkers Daniel mentioned has been the weapon used against these patients for years. But I saw that in November twenty twenty-five, there was a huge announcement about a new diagnostic tool. Is that the nanoneedle device?
That is the one, and it is a total game changer. Developed by researchers at Stanford and the Open Medicine Foundation, this nanoneedle biochip measures how cells respond to stress. They put a small sample of the patient's blood onto this chip and then stress the cells with a tiny amount of salt, which forces them to use energy to maintain their internal balance. In healthy people, the electrical impedance stays stable because their cells have the energy reserves to handle the stress. But in M E C F S patients, the electrical signal spikes. The cells literally cannot handle the stress and they start to fail. It is an objective, measurable biological signature that was incredibly accurate in the early trials. For the first time, we can point to a screen and say, look, your cells are not functioning correctly.
That must be such an emotional moment for someone who has been told for ten years that they are just depressed. It proves the pathology is at the cellular level. It is not a mood disorder; it is a metabolic crisis. But how does this connect to the gut? I keep hearing about the microbiome in relation to these conditions.
The microbiome link is huge and was further solidified by the Duke University BioMap A I tool that came out recently. This A I can identify M E C F S with about ninety percent accuracy just by looking at stool samples and routine lab data. It is finding patterns that a human doctor would never notice. Specifically, patients with these conditions often have much lower levels of butyrate-producing bacteria. Butyrate is a short-chain fatty acid that is essential for gut health and has massive anti-inflammatory effects. When that is missing, you get a leaky gut, which allows bacterial toxins to enter the bloodstream. This fuels systemic inflammation and might even be the source of some of those circulating factors we talked about. There is also an imbalance in tryptophan and benzoate levels, which affects how the brain produces neurotransmitters like serotonin.
So we have this perfect storm. You have a potential viral trigger, which leads to immune dysfunction and autoantibodies, which then messes with the mitochondria and the gut, and eventually, the whole system just shuts down to protect itself. It is a logical biological progression, but it is so complex. Let's talk about the human element Daniel mentioned. What does a day in the life actually look like for someone with a severe case of these conditions? Because I think people hear chronic fatigue and they think, oh, I am tired too. But this is something entirely different.
It is a life of brutal mathematics. Have you ever heard of the spoon theory? It was created by Christine Miserandino to explain life with chronic illness, and it is the best way to visualize it. Imagine most healthy people start the day with an unlimited supply of spoons, or units of energy. You can shower, go to work, go to the gym, meet friends, and you still have spoons left over. But someone with M E C F S might start the day with only twelve spoons. And here is the kicker: every single task costs a spoon. Getting out of bed is one. Taking a shower is three. Making breakfast is two. By the time you are dressed and fed, you might have four spoons left for the entire rest of the day.
And if you use thirteen spoons when you only have twelve, you do not just get tired. You trigger that post-exertional malaise.
You do not just feel sleepy; you crash. You might be bedbound for the next three days because you dared to take a shower and make a sandwich on the same morning. It is a state of constant, high-stakes energy management. You have to choose between washing your hair or calling your mother. You have to choose between answering an email or sitting up to eat dinner. And the cognitive cost is just as high as the physical cost. Thinking, processing information, or even having a conversation takes energy. I read a patient account from March twenty twenty-six, just a few weeks ago, where the person described it as having a brain made of wet concrete. They could see the thoughts they wanted to have, but they could not move them fast enough to speak. This is what we call neuroinflammation. The immune cells in the brain, the microglia, get stuck in an activated state and pump out inflammatory chemicals that slow down neural transmission.
It is like trying to run a high-end video game on a laptop with a broken fan. The system throttles itself to prevent total failure. And then you add the social isolation and the medical gaslighting. I saw a study from twenty twenty-five that said nearly ninety percent of M E C F S patients reported negative mental health impacts, but the researchers were very clear that this was a result of the illness and the way they were treated by the system, not the cause of the fatigue.
The suicide rates in this community are heartbreaking, Corn. In that same study, almost forty percent of patients reported suicidal thoughts. But the most damning statistic is that eighty-nine point five percent of that group cited being told the disease was psychosomatic as the primary driver of their despair. It is one thing to be sick; it is another thing to be sick and have the person who is supposed to help you tell you that you are making it up. It is a form of institutional betrayal that leaves deep scars. For decades, the standard advice was graded exercise therapy, the idea that you just need to get back in shape.
Which we now know is like telling someone with a broken leg to just run a marathon to fix it. If the problem is that exercise literally damages your cells, telling them to exercise is medical malpractice.
It was, and the medical community finally admitted it. The old studies that promoted exercise, like the P A C E trial from twenty eleven, have been thoroughly debunked for massive methodological flaws. The C D C and the N I H finally retired those guidelines in twenty twenty-three and twenty twenty-four, but the word is still trickling down to primary care doctors. There is still a lot of education that needs to happen. We now know that pushing through the fatigue can cause permanent baseline shifts. A patient who was housebound might become completely bedbound if they are forced into an exercise program they cannot handle.
Daniel also asked about treatment options. If exercise is out, what is actually working for people right now? I know there was a big F D A approval recently for fibromyalgia.
Yes, in August twenty twenty-five, the F D A approved Tonmya, which is a sublingual version of cyclobenzaprine. This is the first new drug for fibromyalgia since two thousand seven. What is interesting is that it does not target pain directly. It targets non-restorative sleep. Many of these patients spend eight hours in bed, but their brains never enter the deep, restorative stages of sleep. Tonmya is taken once at night to help the brain actually repair itself during the sleep cycle. If you can fix the sleep, the pain thresholds often improve and the brain fog can lift.
What about the M E C F S side? Are we seeing any pharmacological breakthroughs there?
We are seeing a lot of off-label success with things like low-dose naltrexone, which helps regulate the immune system and reduce neuroinflammation. There are also trials happening with immunoadsorption, which is basically filtering the blood to remove those rogue autoantibodies. In one small study of post-covid patients with M E C F S, removing those antibodies led to significant improvements in their ability to function. We are also seeing people use A I-driven platforms to find personalized supplement protocols based on their specific metabolic gaps, like coenzyme Q ten or magnesium malate. But the real hope lies in the BioQuest study that launched in February twenty twenty-six.
Tell me more about BioQuest. That sounds like the most ambitious effort yet.
It is. The Open Medicine Foundation is looking at four hundred patients and comparing them to healthy controls, but they are also comparing them to people with multiple sclerosis, clinical depression, and burnout. They are using every tool in the shed: metabolomics, lipidomics, proteomics, and cytokine panels. The goal is to identify five to twenty specific molecular biomarkers that can distinguish M E C F S from everything else. If they can validate these, we could see a commercial blood test available by next year. That would mean a patient could get a definitive diagnosis in weeks, not seven years.
It is also a massive economic issue that we need to address. We are talking about millions of people in their prime working years who are being sidelined. The loss of productivity and the strain on the disability system is enormous. It is actually a very pro-growth move to fund this research aggressively. We need to get these people back into the workforce, but they can only do that if we fix the underlying biological brokenness.
And that is why the push for the N I H to merge the long covid and M E C F S research is so important. There was an editorial in Stat News in February twenty twenty-five arguing exactly that. We should not be reinventing the wheel for long covid when M E C F S researchers have been laying the groundwork for forty years. The R E C O V E R initiative has over a billion dollars in funding, and the M E C F S community is rightly demanding that they are included in those clinical trials. We need a unified approach to post-viral illness.
So, if someone is listening to this and they suspect they have one of these conditions, how do they navigate a system that is still catching up? The average diagnosis still takes five to seven years. How do you move faster?
The first thing is to change the language you use with your doctor. Stop saying you are tired. Every patient who walks into a clinic says they are tired. Use the term post-exertional malaise. Describe the crash in detail. Tell them, if I go for a twenty-minute walk, I am in bed for two days starting the next afternoon. That specific timing—the twelve to forty-eight hour delay—is the clinical hallmark of M E C F S. If you have widespread pain, ask for a tender point exam or discuss the new sleep-focused treatments like Tonmya.
You also have to be your own researcher. Groups like the Bateman Horne Center or Solve M E have incredible resources. The Bateman Horne Center published a comprehensive Clinical Care Guide in twenty twenty-five specifically to help primary care physicians who might not be up to date on the latest biomarker research. Bring that guide to your appointment.
And do not accept the psychosomatic label. If a doctor tells you it is just stress, find a new doctor. We now have the Stanford nanoneedle, we have the Duke A I tools, and we have the serum studies proving there is something in the blood. The science is on your side now in a way it never was before. You are not crazy; you are just dealing with a very complex, multi-system biological failure.
What about the future? As we look through the rest of twenty twenty-six, what are you watching for?
I am watching the BioQuest study very closely. I am also watching the trials for H L A-typing. There is some evidence that certain genetic markers make you more susceptible to these post-viral crashes. If we can identify those people early, we might be able to give them preventative treatments during a viral infection to stop the chronic state from ever developing. It is about moving from reactive to proactive medicine. Instead of waiting for someone to be bedbound for a decade, we catch the immune dysfunction in the first month.
That would be a massive victory for public health. I am also interested in the work with Vagus nerve stimulation. Since the Vagus nerve is the main highway between the brain and the immune system, using small electrical pulses to calm that neuroinflammation could be a non-drug way to manage symptoms. There are a few wearable devices in clinical trials right now that look promising.
It is an exciting time, even if it is a difficult one for the people currently in the thick of it. The narrative has shifted. The invisible epidemic is becoming visible. We are finally seeing these conditions for what they are: a breakdown in the most fundamental process of life, which is energy production. Once you can see a problem, you can start to fix it. We spent forty years pretending the problem did not exist because our tools were too blunt to see it. Now that we have the nanoneedles and the A I and the deep metabolomics, the medical community has no more excuses. The era of gaslighting is coming to an end.
I hope so. For everyone out there who is listening to this from their bed or who had to use three spoons just to get through this episode, know that the science is finally catching up to your reality. You have been the pioneers in a territory that medicine was too afraid to map, and the maps are finally being drawn. The resilience of this community is honestly incredible. To live a life of such severe limitation while being told it is not real takes a level of mental strength that most people cannot imagine. They are not weak; they are some of the strongest people on the planet.
Well said, Corn. I think the progress we have seen in just the last twelve to eighteen months gives me more hope than anything I have seen in the previous twenty years of following this research. We are moving into a post-biomarker era where these diseases will be treated with the same rigor as diabetes or heart disease.
We should probably wrap it up there before we run out of spoons ourselves. This has been a deep dive into the changing landscape of M E C F S and fibromyalgia. If you want to dig deeper into the post-viral side of this, we did a full episode on the long covid reality back in episode eight hundred forty-three that is worth a listen. It covers a lot of the foundational context for how we got to this point with the R E C O V E R initiative.
Good call. And a big thanks to the Open Medicine Foundation and Solve M E for the work they do in driving this research. Patient-led research has been the engine of every major breakthrough we discussed today.
Thanks as always to our producer Hilbert Flumingtop for keeping the gears turning behind the scenes. And a big thanks to Modal for providing the G P U credits that power the research and generation of this show. We literally could not do this without that processing power.
This has been My Weird Prompts. If you found this episode helpful or if you know someone who is struggling with these conditions, please share it with them. Spreading the word about the new biomarkers is one of the best ways we can help end the stigma.
You can find us at myweirdprompts dot com for our full archive and all the ways to subscribe. If you are on Telegram, search for My Weird Prompts to get notified the second a new episode drops.
Take care of yourselves out there.
And watch your spoon count. We will talk to you next time.
